Safety considerations of chloroquine in the treatment of patients with diabetes and COVID-19-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Safety considerations of chloroquine in the treatment of patients with diabetes and COVID-19

Published:2022-07 Issue: Volume:361 Page:109954
ISSN:0009-2797
Container-title:Chemico-Biological Interactions
language:en
Short-container-title:Chemico-Biological Interactions

Author:

Gao Xiuge,Jing Xian,Wang Junqi,Zheng Yuling,Qiu Yawei,Ji Hui,Peng Lin,Jiang Shanxiang,Wu Wenda,Guo Dawei

Funder

Priority Academic Program Development of Jiangsu Higher Education Institutions

China Postdoctoral Science Foundation

Publisher

Elsevier BV

Subject

Toxicology,General Medicine

Reference65 articles.

1. http://covid19.Who.Int/.

2. COVID-19 and cardiovascular disease: from basic mechanisms to clinical perspectives;Nishiga;Nat. Rev. Cardiol.,2020

3. COVID-19 and diabetes mellitus: from pathophysiology to clinical management;Lim;Nat. Rev. Endocrinol.,2021

4. COVID-19 and the cardiovascular system;Zheng;Nat. Rev. Cardiol.,2020

5. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study;Zhou;Lancet,2020

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chloroquine: Rapidly withdrawing from first-line treatment of COVID-19;Heliyon;2024-09

2. Identification of a Dual Autophagy and REV-ERB Inhibitor with in Vivo Anticancer Efficacy;Journal of Medicinal Chemistry;2023-12-20

3. Effects of autophagy inhibitor 3-methyladenine on a diabetic mice model;International Journal of Ophthalmology;2023-09-18

4. V-ATPase V0 subunit activation mediates maduramicin-induced methuosis through blocking endolysosomal trafficking in vitro and in vivo;Food and Chemical Toxicology;2023-08

5. Potential RNA-dependent RNA polymerase (RdRp) inhibitors as prospective drug candidates for SARS-CoV-2;European Journal of Medicinal Chemistry;2023-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3